Literature DB >> 6541096

Murine leukemia L1210 cell lines with different patterns of resistance to platinum coordination complexes.

A Eastman, S Illenye.   

Abstract

A murine leukemia L1210 cell line has been developed that exhibits 30-fold resistance to 1,2-diaminocyclohexaneplatinum(II) analogs but retains sensitivity to cisplatin. This contrasts existing cell lines which exhibit the opposite pattern of resistance. Both cell lines retain their sensitivity to melphalan.

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6541096

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN： 0361-5960


  4 in total

1.  Metallothionein-like proteins and cell resistance to cis-dichlorodiammineplatinum(II) in L1210 cells.

Authors:  P Farnworth; B Hillcoat; I Roos
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

2.  Ammine/amine platinum (II) complexes effective in vivo against murine tumors sensitive or resistant to cisplatin and tetraplatin.

Authors:  Z H Siddik; G Thai; M Yoshida; Y P Zhang; A R Khokhar
Journal:  J Cancer Res Clin Oncol       Date:  1994       Impact factor: 4.553

3.  Antitumor activity of cis-malonato[(4R,5R)-4,5-bis(aminomethyl)-2- isopropyl-1,3-dioxolane]platinum(II), a new platinum analogue, as an anticancer agent.

Authors:  D K Kim; H T Kim; Y B Cho; J H Tai; J S Ahn; T S Kim; K H Kim; W S Hong
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

4.  [DL-1,2-bis(2-hydroxyphenyl)ethylenediamine]dichloroplatinum(II), a new compound for the therapy of ovarian cancer.

Authors:  R Müller; R Gust; G Bernhardt; C Keller; H Schönenberger; S Seeber; R Osieka; A Eastman; M Jennerwein
Journal:  J Cancer Res Clin Oncol       Date:  1990       Impact factor: 4.553
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.